Success Metrics

Active Trials
3(75%)

Phase Distribution

Ph phase_2
4
100%

Phase Distribution

0

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
4(100.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(4)

Detailed Status

Recruiting3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 24 (100.0%)

Trials by Status

recruiting375%
not_yet_recruiting125%

Recent Activity

3 active trials
Showing 4 of 4
not_yet_recruitingphase_2

Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis

NCT07549841
recruitingphase_2

BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

NCT07629609
recruitingphase_2

Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer

NCT06540872
recruitingphase_2

[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

NCT07215182

Clinical Trials (4)

Showing 4 of 4 trials
NCT07549841Phase 2

Exploratory Study Evaluating the Relevance of [68Ga]Ga-FAPI-46 for Staging and Identifying Progressing Patients With Transthyretin Cardiac Amyloidosis

Not Yet Recruiting
NCT07629609Phase 2

BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

Recruiting
NCT06540872Phase 2

Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive Cancer

Recruiting
NCT07215182Phase 2

[68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

Recruiting

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4